Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis.

Goswami, Rudra P; Ray, Animesh; Chatterjee, Moumita; Mukherjee, Arindam; Sircar, Geetabali; Ghosh, Parasar

Goswami, Rudra P; Ray, Animesh; Chatterjee, Moumita; Mukherjee, Arindam; Sircar, Geetabali; Ghosh, Parasar.

Afiliação

Goswami RP; Department of Rheumatology, All India Institute of Medical Sciences, New Delhi, India.
Ray A; Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Chatterjee M; Department of Mathematics and Statistics, Aliah University, Kolkata, India.
Mukherjee A; Department of Pulmonology, TATA Medical Center, Rajarhat, Kolkata, India.
Sircar G; Department of Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India.
Ghosh P; Department of Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India.

Rheumatology (Oxford) ; 60(2): 557-567, 2021 02 01.

Article em En | MEDLINE | ID: mdl-33164098

Assuntos

Doenças Pulmonares Intersticiais/tratamento farmacológico; Rituximab/uso terapêutico; Escleroderma Sistêmico/complicações; Humanos; Fatores Imunológicos/uso terapêutico; Doenças Pulmonares Intersticiais/etiologia; Escleroderma Sistêmico/tratamento farmacológico

Palavras-chave

anti-CD20; interstitial lung disease; meta-analysis; rituximab; scleroderma; systematic review; systemic sclerosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Doenças Pulmonares Intersticiais / Rituximab Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google